Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.
Diabetes Obes Metab
; 21(7): 1737-1744, 2019 07.
Article
in En
| MEDLINE
| ID: mdl-30830727
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Benzoxazoles
/
Butyrates
/
Hypertriglyceridemia
/
Diabetes Mellitus, Type 2
/
Hypolipidemic Agents
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2019
Type:
Article
Affiliation country:
Japan